178 related articles for article (PubMed ID: 28261902)
1. Estimates of live birth prevalence of children with Down syndrome in the period 1991-2015 in the Netherlands.
de Graaf G; Engelen JJM; Gijsbers ACJ; Hochstenbach R; Hoffer MJV; Kooper AJA; Sikkema-Raddatz B; Srebniak MI; van der Kevie-Kersemaekers AMF; van Zutven LJCM; Voorhoeve E
J Intellect Disabil Res; 2017 May; 61(5):461-470. PubMed ID: 28261902
[TBL] [Abstract][Full Text] [Related]
2. Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population-based register study.
de Groot-van der Mooren M; de Graaf G; Weijerman ME; Hoffer MJV; Knijnenburg J; van der Kevie-Kersemaekers AMF; Kooper AJA; Voorhoeve E; Sikkema-Raddatz B; van Zutven LJCM; Srebniak MI; Huijsdens-van Amsterdam K; Engelen JJM; Smeets D; van Kaam AH; Cornel MC
Prenat Diagn; 2021 Sep; 41(10):1351-1359. PubMed ID: 34176145
[TBL] [Abstract][Full Text] [Related]
3. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome: effects of demographic factors and prenatal diagnosis on the future livebirth prevalence.
Cornel MC; Breed AS; Beekhuis JR; te Meerman GJ; ten Kate LP
Hum Genet; 1993 Sep; 92(2):163-8. PubMed ID: 8370583
[TBL] [Abstract][Full Text] [Related]
5. Unchanged prevalence of Down syndrome in the Netherlands: results from an 11-year nationwide birth cohort.
van Gameren-Oosterom HB; Buitendijk SE; Bilardo CM; van der Pal-de Bruin KM; Van Wouwe JP; Mohangoo AD
Prenat Diagn; 2012 Nov; 32(11):1035-40. PubMed ID: 22865545
[TBL] [Abstract][Full Text] [Related]
6. Trends in live birth prevalence of down syndrome in the Northern Netherlands 1987-96: the impact of screening and prenatal diagnosis.
Wortelboer MJ; De Wolf BT; Verschuuren-Bemelmans CC; Reefhuis J; Mantingh A; Beekhuis JR; Cornel MC
Prenat Diagn; 2000 Sep; 20(9):709-13. PubMed ID: 11015698
[TBL] [Abstract][Full Text] [Related]
7. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States.
de Graaf G; Buckley F; Skotko BG
Am J Med Genet A; 2015 Apr; 167A(4):756-67. PubMed ID: 25822844
[TBL] [Abstract][Full Text] [Related]
8. A population-based study of prevalence of Down syndrome in Southern Thailand.
Jaruratanasirikul S; Kor-Anantakul O; Chowvichian M; Limpitikul W; Dissaneevate P; Intharasangkanawin N; Sattapanyo A; Pathompanitrat S; Sriplung H
World J Pediatr; 2017 Feb; 13(1):63-69. PubMed ID: 27878784
[TBL] [Abstract][Full Text] [Related]
9. Equipoise of recent estimated Down syndrome live births in Japan.
Sasaki A; Sago H
Am J Med Genet A; 2019 Sep; 179(9):1815-1819. PubMed ID: 31313514
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, prenatal screening and neonatal features in children with Down syndrome: a registry-based national study.
Glivetic T; Rodin U; Milosevic M; Mayer D; Filipovic-Grcic B; Seferovic Saric M
Ital J Pediatr; 2015 Oct; 41():81. PubMed ID: 26511759
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of live birth Down syndrome in the region of Primorsko-goranska County in Croatia, 1996-2005: the impact of screening and amniocentesis.
Brajenović-Milić B; Prpić I; Petrović O; Ristić S; Brumini G; Kapović M
Matern Child Health J; 2008 Sep; 12(5):620-3. PubMed ID: 17712614
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the number of people with Down syndrome in Europe.
de Graaf G; Buckley F; Skotko BG
Eur J Hum Genet; 2021 Mar; 29(3):402-410. PubMed ID: 33130823
[TBL] [Abstract][Full Text] [Related]
13. Prenatal genetic diagnosis and elective abortion in women over 35: utilization and relative impact on the birth prevalence of Down syndrome in Washington State.
Luthy DA; Emanuel I; Hoehn H; Hall JG; Powers EK
Am J Med Genet; 1980; 7(3):375-81. PubMed ID: 6451173
[TBL] [Abstract][Full Text] [Related]
14. Recent trends in the birth prevalence of Down syndrome in China: impact of prenatal diagnosis and subsequent terminations.
Deng C; Yi L; Mu Y; Zhu J; Qin Y; Fan X; Wang Y; Li Q; Dai L
Prenat Diagn; 2015 Apr; 35(4):311-8. PubMed ID: 25315427
[TBL] [Abstract][Full Text] [Related]
15. Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013.
de Groot-van der Mooren MD; Tamminga S; Oepkes D; Weijerman ME; Cornel MC
Eur J Hum Genet; 2018 Feb; 26(2):157-165. PubMed ID: 29330546
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Down syndrome in Glasgow, 1980-96--the growing impact of prenatal diagnosis on younger mothers.
Iliyasu Z; Gilmour WH; Stone DH
Health Bull (Edinb); 2002 Jan; 60(1):20-6. PubMed ID: 12664764
[TBL] [Abstract][Full Text] [Related]
17. [Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
de Vigan C; Khoshnood B; Cadio E; Vodovar V; Goffinet F
Gynecol Obstet Fertil; 2008 Feb; 36(2):146-150. PubMed ID: 18249576
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the number of people with Down syndrome in Australia and New Zealand.
de Graaf G; Skladzien E; Buckley F; Skotko BG
Genet Med; 2022 Dec; 24(12):2568-2577. PubMed ID: 36194210
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing.
Engels MA; Bhola SL; Twisk JW; Blankenstein MA; van Vugt JM
Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():59-63. PubMed ID: 24405726
[TBL] [Abstract][Full Text] [Related]
20. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
